Hannah Churchill reports on the Alzheimer’s Society Annual Conference (22–23 May, London, UK), including preventative risk factors, technology and dementia, as well as drug repurposing.
Browsing: research strategies
The UK DRI’s COO, Adrian Ivinson, discusses the UK DRI and the current dementia care research landscape, as well as new opportunities for dementia researchers to join the Institute.
CYP2D6 and CYP2C19 genotyping in psychiatric patients on psychotropic medication in the former Dutch Antilles
In this research article from Pharmacogenomics discover the prevalence of CYP2D6 and CYP2C19 polymorphisms in psychiatric patients and volunteers from Dutch caribbean origin.
The aim of this study was to examine the possible correlation between IGF-I levels in serum in large vestibular schwannomas and its potential neuroprotective effect on the vestibulocochlear nerve.
Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein–huprine hybrids
In this research article from Future Medicinal Chemistry discover the potential of second-generation naphthyridine- and thienopyridine-based rhein–huprine hybrids in Alzheimer’s disease.
Depression, anxiety, and stress severities in multiple sclerosis patients using injectable vs. oral treatments
This study measures severities of depression, anxiety and stress, and compares them to the used disease-modifying treatment.
Listen our recent panel discussion, held in collaboration with The Drake Foundation, to hear from our experts as they discuss the current issues surrounding brain banking.
A group of researchers report the intrinsic role of spindle matrix proteins in regulating neural stem cell reactivation and proliferation. The findings could contribute to the development of stem cell-based therapies for neurological disorders.
Researchers have demonstrated that the enzymatic activity of R5 receptor-type protein tyrosine phosphatases is a requisite for the maintenance of stem cell properties and tumorigenicity in glioblastoma cells and could be a promising drug target for treatment.
Researchers have identified a novel mechanism by which cells die in Alzheimer’s disease, which my aid future therapies targeting cell loss in the brain.